Table 2. Availability of Medication for the Treatment of Opioid Use Disorder Among Pregnant Individuals in US Jails.
MOUD availability | Jails, No./total No. (%) |
---|---|
During pregnancy | |
MOUD availablea | 504/836 (60.3) |
Continuation only | 237/504 (47.0) |
Initiation and continuation | 267/504 (53.0) |
Methadone available | 385/504 (76.4) |
Continuation only | 247/385 (64.2) |
Initiation and continuation | 137/385 (35.6) |
Buprenorphine available | 381/504 (75.6) |
Continuation only | 171/381 (44.9) |
Initiation and continuation | 210/381 (55.1) |
Methadone only available | 123/504 (24.4) |
Continuation only | 84/123 (68.3) |
Initiation and continuation | 39/123 (31.7) |
Buprenorphine only available | 119/504 (23.6) |
Continuation only | 46/119 (38.7) |
Initiation and continuation | 73/119 (61.3) |
Both methadone and buprenorphine available | 262/504 (52.0) |
Continuation only | 107/262 (40.8) |
Initiation and continuation | 152/262 (58.0) |
Withdrawal only (no MOUD available)b | 190/577 (32.9) |
Withdrawal and MOUD availablec | 387/577 (67.1) |
During postpartum period | |
MOUD available for continuationd | 120/504 (23.8) |
No MOUD continuation | 274/504 (54.4) |
Discontinuation with tapering | 165/274 (60.2) |
Abrupt discontinuation | 61/274 (22.3) |
Conditional discontinuatione | 47/274 (17.2) |
Did not report | 110/504 (21.8) |
Abbreviation: MOUD, medication for opioid use disorder.
Data do not include jails for which the provision of MOUD was uncertain.
There was a higher likelihood of doing withdrawal only among paper responses than among online responses (126 vs. 64; P = .01).
There was a higher likelihood of doing withdrawal and MOUD among paper responses than among online responses (267 vs. 120; P = .03).
Among jails providing MOUD during pregnancy.
Some respondents stated that they did not routinely continue providing MOUD after pregnancy but would consider allowing it depending on the remaining time in an individual’s jail sentence or whether an individual was expressing breast milk.